Recently, a federal jury ordered Monsanto to pay $80 million to 70-year-old Edwin Hardeman, who got diagnosed with cancer after using their weed killer for 26 years. The weed killer in question, Roundup, is a glyphosate-based herbicide that Hardeman regularly used on his 56-acre property…
With thousands of reported side effects, the blood thinning drug Xarelto has been controversial since its initial approval for medical use in 2011. Nevertheless, Johnson & Johnson (J&J) submitted a Supplemental New Drug Application on Dec. 14 for Xarelto to be used as a preventative…
The FDA recently issued a warning dissuading customers from using Rhino male sexual enhancement products, which are unregulated supplements typically found for sale at gas stations and convenience stores. This warning comes after the discovery that many Rhino supplements contain unlisted ingredients that could cause…
Starting in July of this year, the U.S. Food & Drug Administration (FDA) began issuing a series of recalls for heart medication valsartan—most due to entire batches of the drug testing positive for N-Nitrosodiethylamine (NDEA), a chemical that can lead to liver damage, tumors and,…
You might be familiar with Pradaxa—a blood-thinning medication that is used to prevent blood clots and strokes in heart arrhythmia patients and manufactured by Boehringer Ingelheim Pharmaceuticals Incorporated (BIPI). What you might not be aware of are the claims that their product marketing was misleading…
In July, the Food and Drug Administration (FDA) issued a voluntary recall of multiple medications containing valsartan that were manufactured by the Chinese pharmaceutical company, Zhejiang Huahai. The recall occurred after two likely carcinogenic chemicals, N-nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA), were detected in the product—a…